Invention Grant
- Patent Title: Indole derivatives useful as glucagon receptor antagonists
-
Application No.: US15695107Application Date: 2017-09-05
-
Publication No.: US10251864B2Publication Date: 2019-04-09
- Inventor: Micheal Gaul , Guozhang Xu , Bao-Ping Zhao
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee: JANSSEN PHARMACEUTICA NV
- Current Assignee Address: BE Beerse
- Agency: Porzio, Bromberg & Newman P.C.
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; A61K31/404 ; A61K31/4412 ; A61K31/166 ; A61K31/198 ; C07D401/06 ; C07D409/04 ; C07D209/08
Abstract:
The present invention is directed to indole derivatives, pharmaceutical compositions containing them and their use in the treatment and/or prevention of disorders and conditions ameliorated by antagonizing one or more glucagon receptors, including for example metabolic diseases such as Type II diabetes mellitus and obesity.
Public/Granted literature
- US20180064686A1 INDOLE DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS Public/Granted day:2018-03-08
Information query
IPC分类:
